Abstract

BackgroundDeleted in malignant brain tumors 1 (DMBT1) is an innate defence protein expressed in the lungs of preterm infants and adults. Recent studies showed that DMBT1 is important in angiogenesis and can bind to different growth factors including VEGF. We aimed at examining relationships between VEGF and IL-6 levels to DMBT1 expression in the lungs of preterm and term infants and in lung epithelial cells in vitro.MethodsWe examined by ELISA VEGF levels in 120 tracheal aspirates of 57 preterm and term infants and tested for correlation with different perinatal factors as well as with DMBT1 levels. To examine the effect of DMBT1 on VEGF and IL-6 expression we compared type II lung epithelial A549 cells stably transfected with a DMBT1 expression plasmid (DMBT1+ cells) to A549 cells stably transfected with an empty expression plasmid (DMBT1- cells). The concentrations of VEGF and IL-6 were determined via ELISA in the supernatant of the unstimulated cells and after stimulation with LPS, TNFα and Phorbol-12-myristate-13-acetate (PMA).ResultsThe VEGF levels in the tracheal aspirates of preterm and term infants were significantly correlated with DMBT1 levels (p = 0.0032), the postnatal age (p = 0.0073) and the presence of neonatal infection/sepsis (p = 0.0002). Unstimulated DMBT1+ A549 cells showed significantly higher VEGF expression (p = 0.0017) than DMBT1- cells. Significantly elevated VEGF levels were also confirmed for DMBT1+ cells after stimulation with TNFα (p = 0.0008), LPS (p = 0.0232) and PMA (p = 0.0025). The IL-6 levels were comparable in DMBT1+ versus DMBT1- cells without stimulation (p = 0.6028), but they were significantly reduced in DMBT1+ cells after stimulation with TNFα (p = 0.0003), LPS (p = 0.0088) and PMA (p = 0.0039).ConclusionsThe data indicate that DMBT1 promotes VEGF and suppresses IL-6 production in alveolar tissues, which could point to DMBT1 having a possible role in the transition from inflammation to regeneration and being a potentially useful clinical marker.

Highlights

  • Deleted in malignant brain tumors 1 (DMBT1) is an innate defence protein expressed in the lungs of preterm infants and adults

  • To adjust for different dilution factors associated with this procedure, we normalized the measured concentrations of vascular endothelial growth factor (VEGF) or DMBT1 to the total protein content, which was detected with the bicinchoninic acid (BCA) protein assay (Pierce, Rockford, IL, USA)

  • We performed a multiple regression analysis including these factors, which have been revealed as statistically significant, in the univariate analyses. This led to the following mathematical equation: y 1⁄4 0:2840 þ 0:007356x1 þ 0:1569x2 þ x3 where Y is the relative VEGF level in the unknown tracheal aspirate, which is significantly influenced by the parameters postnatal age, the relative DMBT1 level expressed as percentage of the total protein concentration in the tracheal aspirate (X2, p = 0.0159) and the presence or absence of neonatal infection/sepsis (x3 = 0.4891, if the infant has an infection/sepsis or x3 = 0 in the absence of infection/ sepsis; p = 0.0038)

Read more

Summary

Introduction

Deleted in malignant brain tumors 1 (DMBT1) is an innate defence protein expressed in the lungs of preterm infants and adults. VEGF is highly expressed in the lung and has multiple functions in the pulmonary tissue: It is necessary for lung development as well as for the structural maintenance during adult life [9,10,11]. VEGF plays a role in respiratory diseases of preterm infants, in the alveolarization of preterm lungs with respiratory distress syndrome characterized by edema and pulmonary inflammation, and in lungs with bronchopulmonary dysplasia [8,13,16,17]. VEGF is important for the pulmonary endothelial cells by functioning as a mitogen, survival and differentiation factor, promoting angiogenesis, and regulating the permeability of the endothelium [9]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call